Every patient’s cancer is unique and every patient responds to cancer drugs differently. But right now, all patients with the same kind of cancer are treated with the same drugs. SEngine Precision Medicine is hoping to change that with new platform, called PARIS, that grows and analyzes a patient’s cancer cells to figure out which drugs […]
Perspectives
s2s PR Representing Xconomy “What’s Hot in Seattle Biotech” Speakers
We’re proud to have cultivated the speaking engagement for Phase Genomics. CEO Ivan Liachko will present on the convergence of technology and the life sciences on June 12th in Seattle, alongside other biotech innovators such as Adaptive Biotechnologies and Silverback Therapeutics. Find the details and join us here: https://www.xconomy.com/whats-hot-in-seattle-biotech/speakers/
SEngine Discovery of Common Link in 28% of all Cancers Makes Medical, Life Science News
Scientists from Cure First and SEngine Precision Medicine discover common link in 28% of all cancers Read the story here
Testimonial: Opticyte
“s2s PR helped transform our complex medical messaging into a compelling and human story for both investors and potential partners. They helped increase the impact of presentations and branding to bring us closer to our business goals.” – Robert V. Masterson, CEO Opticyte, Inc
Seattle Business Magazine features SEngine Precision Medicine
SEngine Precision Medicine CEO Dr. Carla Grandori showcases SEngine’s scientific edge in functional precision oncology:
KOMO 4 Appearance: Female Founders Alliance Speaks about Tech and VC Gender Gap
Female Founders Alliance Founder, Leslie Feinzaig speaks with KOMO 4’s Mary Nam about the inaugural Champion Awards honoring advocates for women founders in tech, launching Female Founders Alliance and the rapid international growth of the organization. s2s PR happy to help make the media opportunity a reality. See the entire clip from the February 2018 appearance […]
Client Voice: The Future of Fighting Cancer
Read SEngine Precision Medicine CEO Dr. Carla Grandori’s article about the future of personalize cancer treatment, Young Lions https://www.linkedin.com/pulse/young-lions-harnessing-next-generation-technologies-carla/?published=t
Q13 FOX News Covers the Game-Changing Vermouth App
See Founder Jamien McCullum speak about the future of the trust-economy and Vermouth on FOX Q13
SEngine Precision Medicine in GenomeWeb
Read the article as SEngine as emerges as the first Functional Precision Medicine lab to receive CLIA certification
Testimonial: SEngine Precision Medicine
Eric distilled our complex subject matter, creating and posting compelling content on our social channels including LinkedIn. This increased vital awareness of our cancer-fighting technology, and even led directly to engaging high value talent to join our team and help our biotech grow. – Carla Grandori, MD, Ph.D., CEO SEngine Precision Medicine